DrugsControl Media Services

News Detail

NPPA delinks compliance to IPDMS or WPA for price approval of new drugs (21-12-2017)

Mumbai, 21 Dec 2017: In a big relief to several pharmaceutical companies whose Form I applications has been pending due to non compliance to Integrated Pharma Database Management (IPDMS) or because of launch of new drug without prior approval (WPA), the National Pharmaceutical Pr......
View Details

Source : Pharmabiz

Related News